These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38278734)

  • 1. Prognostic significance of lncRNA AL354919.2 in bladder cancer.
    Mao Q; Liu H; Wu J; Cui Y
    Asian J Surg; 2024 May; 47(5):2410-2412. PubMed ID: 38278734
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
    Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
    Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Bao Z; Zhang W; Dong D
    Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify
    Shen D; Zhang Y; Zheng Q; Yu S; Xia L; Cheng S; Li G
    DNA Cell Biol; 2021 Jan; 40(1):26-35. PubMed ID: 33270518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer.
    Lai C; Wu Z; Shi J; Li K; Zhu J; Chen Z; Liu C; Xu K
    Aging (Albany NY); 2020 Nov; 12(21):21582-21596. PubMed ID: 33175697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an immune-related LncRNA signature with prognostic significance for bladder cancer.
    Luo WJ; Tian X; Xu WH; Qu YY; Zhu WK; Wu J; Ma CG; Zhang HL; Ye DW; Zhu YP
    J Cell Mol Med; 2021 May; 25(9):4326-4339. PubMed ID: 33797188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
    Zhang S; Zhong G; He W; Yu H; Huang J; Lin T
    J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
    Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
    Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
    Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
    J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Long Non-coding RNA Markers for Prognostic Prediction of Patients with Bladder Cancer.
    Li WX; Zhang YL
    Chin Med Sci J; 2020 Sep; 35(3):239-247. PubMed ID: 32972501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
    Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
    J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
    Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma.
    Gao X; Zhang S; Chen Y; Wen X; Chen M; Wang S; Zhang Y
    J Cell Biochem; 2019 Dec; 120(12):19796-19809. PubMed ID: 31338862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.
    Li Z; Jiang L; Zhang Z; Deng M; Wei W; Tang H; Guo S; Ye Y; Yao K; Liu Z; Zhou F
    Cancer Med; 2022 Jan; 11(2):539-552. PubMed ID: 34816620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA: "LNCs" to cancer.
    Sültmann H; Diederichs S
    Eur Urol; 2014 Jun; 65(6):1152-3. PubMed ID: 24508069
    [No Abstract]   [Full Text] [Related]  

  • 17. Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells.
    Zangouei AS; Rahimi HR; Mojarrad M; Moghbeli M
    Diagn Pathol; 2020 Nov; 15(1):136. PubMed ID: 33183321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
    Jiang J; Bi Y; Liu XP; Yu D; Yan X; Yao J; Liu T; Li S
    J Cell Mol Med; 2020 May; 24(9):5375-5386. PubMed ID: 32233022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CARLo-7-A plausible biomarker for bladder cancer.
    Amir H; Khan MA; Feroz S; Bibi N; Nawaz M; Mehmood A; Yousuf A; Khawaja MA; Khadim MT; Tariq A
    Int J Exp Pathol; 2019 Feb; 100(1):25-31. PubMed ID: 30883984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
    Feng ZH; Liang YP; Cen JJ; Yao HH; Lin HS; Li JY; Liang H; Wang Z; Deng Q; Cao JZ; Huang Y; Wei JH; Luo JH; Chen W; Chen ZH
    J Transl Med; 2022 Oct; 20(1):492. PubMed ID: 36309694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.